oligodendrocyte therapy (BlueRock Therapeutics)

N/A

Report date: 2025/03/19 11:43:41

Base Information

Drug Nameoligodendrocyte therapy (BlueRock Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionNeuroprotectantsCNS modulators
TargetsUpdating
Therapy Area/IndicationsDemyelinating Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBluerock Therapeutics Lp
China Registration ClassN/A

Develop Information

Active CompaniesBluerock Therapeutics Lp
Inactive CompaniesN/A
Active IndicationsDemyelinating Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A